Additional information
Light yellow Powder
NA
ACI-090420
[1,4`-Bipiperidine]-1`-carboxylic acid, (4S)-4-ethyl,11-(1-methylethyl)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3`,4`:6,7] indolizino[1,2-b]quinolin-9-yl ester
[1,4-Bipiperidine]-1-carboxylic acid, (4S)-4-ethyl,11-(1-methylethyl)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinolin-9-yl ester
C34H40ClN4O6
600.7
Ambient
2-8°C
[1,4-Bipiperidine]-1-carboxylic acid, (4S)-4-ethyl,11-(1-methylethyl)-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3,4:6,7]indolizino[1,2-b]quinolin-9-yl ester
Antineoplastic medications





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)